Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)Integrated health industry city site that will be a world model for self-sustained growth of human resources and technology (COI-NEXT)

TOPICS

  • Topics
  • Activity report
  • Results
  • Acknowledgement

We exhibited at the Osaka Kansai EXPO Pre-Event "Connecting You to the Future, Science Exhibition" (Tokyo Innovation Base), held from February 13th to 16th. At our base, we exhibited Danionella cerebrum handled by the Kento Imaging Support Center and the National Cardiovascular Center Department of Cardiac Regeneration Biology, entitled "The New World of Microscopic Imaging: Danionella cerebrum".
Many people, including families and base personnel, stopped by to see the exhibit.
The actual event will be held from August 14th to 19th at the EXPO Messe (Yumeshima) in the Osaka Kansai EXPO site.

If you are visiting the Expo, please stop by!

EXPO 2025 pre-event " Science : Connecting You to the Future. "

EXPO 2025 pre-event " Science : Connecting You to the Future. "

On Tuesday, January 14th, the nine PI Development Program recipients, organizers, and recommenders gathered on-site to hold a progress report meeting (general meeting).The organizers gave advice to each recipient‘s presentation, and lively discussions were held.
This time, there was also advice from two recipients of the Japan Science and Technology Agency (JST) and the Japan Advanced Research and Development Agency (AMED-PRIME) programs, and the discussion was held to deepen strategies for obtaining competitive funding in the future.

We will continue to actively support recipients in the future.

Report on the PI Development Program Progress Report General Meeting

Report on the PI Development Program Progress Report General Meeting

The 4th Startup Seminar was held on Monday, November 25th.
This time, the seminar was titled “Pharmaceutical Manufacturers and Academia Roundtable,” and participants discussed how research professors and startups should interact with pharmaceutical manufacturers from the perspectives of pharmaceutical manufacturers and academia. It was a very meaningful seminar, as we were able to hear specific and frank opinions about challenges and ideal situations regarding collaboration with pharmaceutical manufacturers.

We would like to express our sincere gratitude to everyone who participated. Please join us for future startup seminars!

◆ JST COI-NEXT Program × Life Science Incubation Council
Pharmaceutical Manufacturers and Academia Roundtable
· Date snd time : November 25th (Mon), 2024 18:00-19:30 JST
· The venue : LINK-J WEST

· Speakers :
(Moderator)
Cabinet Office Bioeconomy Strategy Expert/LSIC
Organizer, Lawyer Yoshizawa Nao
(Panelists)
Shiono Soichi, Shionogi & Co., Ltd.
Maeda Tomoko, Nippon Boehringer Ingelheim Co., Ltd.
Suzuki Shinobu, Kyoto University

Report on the 4th Startup Seminar

Report on the 4th Startup Seminar

The 3rd Startup Seminar was held on Tuesday, November 5th.
This time, we held a VC capitalist roundtable discussion, with Mikio Kawahara of Utokyo Innovation Platform Co., Ltd., Hiroyuki Hasegawa of Mitsubishi UFJ Capital Co., Ltd., and Hajime Oshita of Medventure partners,Inc.. They discussed what kind of healthcare startups VCs are looking for and what points to consider when evaluating them.

We would like to express our sincere gratitude to everyone who participated. Please join us for future startup seminars!

◆ JST COI-NEXT Program × Life Science Incubation Council
VC capitalist roundtable
· Date snd time : November 5th (Tue), 2024 18:00-19:30 JST
· The venue : LINK-J WEST

· Speakers :
Utokyo Innovation Platform Co., Ltd. Mikio Kawahara
Mitsubishi UFJ Capital Co.,Ltd. Hiroyuki Hasegawa
Medventure partners, Inc. Hajime Oshita

Report on the 3rd Startup Seminar

Report on the 3rd Startup SeminarUpcoming Startup Seminars

When research related to this program or research using the equipment installed in the "Kento Imaging Support Center" is published in a paper, it will be introduced on the website of the Place for Co-Creation and reported to JST as an achievement.

[ Research related to this program ]
Please indicate your grant number below.
Grant number of the Co-Creation Field: JPMJPF2018
When your paper is accepted, please inform the Co-Creation Field Support Office.
We will publish your paper as a result on the website of Place for Co-Creation.

( For inquiries, please contact )
National Cerebral and Cardiovascular Center
Open Innovation Center, Industry-Academia Collaboration Division
6-1 Kishibe Shinmachi, Suita City, Osaka, Japan
E-mail: coi-next-so@ml.ncvc.go.jp
TEL: 06-6170-1070

List of TOPICS >

  • Northern Osaka Health and Biomedical Innovation Town KENTO
  • ational Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN)
  • National University Corporation Tokushima University
  • Eisai Co., Ltd.
  • Towa Pharmaceutical Co., Ltd.
  • Sysmex Corporation
  • Nipro Corporation
  • JSR Corporatio
  • CYBERDYNE, Inc.
  • crossEffect, Inc.
  • CMIC HOLDINGS Co., Ltd.
  • Osaka Chamber of Commerce and Industry
  • Osaka Prefectural Government
  • Suita City
  • Settsu City
  • Mediford Corporation
  • Mizuho Bank, Ltd.
  • Kobe University
  • AIR WATER INC.
  • Kowa Company, Ltd.
  • JSPA(Japan Selfcare Promotion Association)
  • The SC approved MUFG Bank
  • Hankyu Hanshin Holdings Co., Ltd.
  • JCR Pharma Co., Ltd.
  • NEXGEN Co., Ltd.
  • Kyoto University
  • Osaka University
  • Shiga University of Medical Science
  • Kobe Pharmaceutical University
  • Osaka Metropolitan University
  • The Research Foundation for Microbial Diseases of Osaka University
  • Wellier Corporation
  • General Incorporated Association KENTO Co-Creation Promotion Organization (KCOP)